Trinity Biotech (TRIB) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear

Trinity Biotech

NASDAQ: TRIB · Real-Time Price · USD
1.15
0.09 (8.62%)
At close: Oct 03, 2025, 3:59 PM
1.13
-1.74%
After-hours: Oct 03, 2025, 07:43 PM EDT

Trinity Biotech Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
61.55M 56.83M 62.52M 81.15M
Cost of Revenue
40.11M 37.38M 52.73M 54.89M
Gross Profit
21.44M 19.45M 22.05M 33.45M
Operating Income
-21.16M -27.05M -15.27M 3.94M
Interest Income
n/a 1.17M 303K 1.22M
Pretax Income
-30.73M -36.93M -43.78M -1.92M
Net Income
-31.79M -24.02M -41M 875K
Selling & General & Admin
28.82M 31.15M 29.17M 24.68M
Research & Development
4.54M 4.38M 4.14M 4.5M
Other Expenses
9.25M 10.96M -343K 336K
Operating Expenses
42.61M 46.49M 32.96M 29.52M
Interest Expense
9.56M 10.15M 24.73M 7.1M
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
82.72M 83.88M 81.87M 77.21M
Income Tax Expense
486K -59K 194K -74K
Shares Outstanding (Basic)
17.96M 7.65M 6.75M 4.18M
Shares Outstanding (Diluted)
17.96M 7.65M 7.77M 5.33M
EPS (Basic)
-1.77 -3.2 -6 0.21
EPS (Diluted)
-1.77 -3.2 -5.2 0.16
EBITDA
-16.91M -24.1M -16.71M 10.59M
EBIT
-18.77M -25.87M -19.05M 7.85M
Depreciation & Amortization
1.86M 1.78M 2.33M 2.74M